We herein demonstrated that the CaMKII inhibitors KN-93 and acremomannolipin A prevented the development of diet-induced obesity in mice presumably through the suppression of adipogenic differentiation, cell proliferation, and lipid accumulation in adipocytes. This evidence concerns the gene CAMK2G and obesity disorder.